Pacira BioSciences (PCRX) Total Debt (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Total Debt of $367.7 million for Q1 2026, up 21.11% year-over-year from $303.6 million in Q1 2025, and down 1.22% quarter-over-quarter from $372.2 million in Q4 2025.
Pacira BioSciences (PCRX) Total Debt (2010 - 2026) Analysis & Trends
Pacira BioSciences' Total Debt history runs 15 years deep, the most recent figure standing at $367.7 million for Q1 2026.
- In Q1 2026, Total Debt rose 21.11% year-over-year to $367.7 million; the TTM figure through Mar 2026 stood at $367.7 million (up 21.11% YoY), while the FY2025 annual figure was $372.2 million, down 52.71% from the prior year.
- Total Debt for Q1 2026 stood at $367.7 million, down from $372.2 million in the prior quarter.
- The five-year high for Total Debt was $787.1 million in Q4 2024, with the low at $109.8 million in Q2 2024.
- The 5-year median for Total Debt is $309.8 million (2022), against an average of $337.3 million.
- The sharpest annual moves came in 2023 and 2025: Total Debt plunged 61.93% in 2023, then jumped 173.55% in 2025.
- Pacira BioSciences' Total Debt stood at $723.1 million in 2022, then declined by 26.56% to $531.1 million in 2023, then jumped by 48.21% to $787.1 million in 2024, then tumbled by 52.71% to $372.2 million in 2025, then dropped by 1.22% to $367.7 million in 2026.
- Business Quant data shows PCRX's Total Debt at $367.7 million in Q1 2026, $372.2 million in Q4 2025, and $376.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 760.00 Mn |
| 10 | Pacira BioSciences | 943.54 Mn | 692.51 Mn | 148.24 Mn | 363.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 363.12 Mn |
| Mar 31, 2026 | 367.66 Mn |
| Dec 31, 2025 | 372.19 Mn |
| Sep 30, 2025 | 376.72 Mn |
| Jun 30, 2025 | 300.23 Mn |
| Mar 31, 2025 | 303.58 Mn |
| Dec 31, 2024 | 787.10 Mn |
| Sep 30, 2024 | 308.49 Mn |
| Jun 30, 2024 | 109.75 Mn |
| Mar 31, 2024 | 121.12 Mn |
| Dec 31, 2023 | 531.08 Mn |
| Sep 30, 2023 | 117.97 Mn |
| Jun 30, 2023 | 143.46 Mn |
| Mar 31, 2023 | 148.39 Mn |
| Dec 31, 2022 | 723.12 Mn |
| Sep 30, 2022 | 309.85 Mn |
| Jun 30, 2022 | 352.12 Mn |
| Mar 31, 2022 | 360.51 Mn |
| Dec 31, 2021 | 685.73 Mn |
| Sep 30, 2021 | 155.75 Mn |